Recent advances in the synthesis of Quinazoline analogues as Anti-TB agents

被引：40
|
作者：
Dutta, Apurba [1 ]
Sarma, Diganta [1 ]
机构：
[1] Dibrugarh Univ, Dept Chem, Dibrugarh 786004, Assam, India
来源：
TUBERCULOSIS | 2020年 / 124卷
关键词：
Mycobacterium tuberculosis; Anti-tubercular drugs; Heterocyclic chemistry; Quinazoline analogues; Structure-activity relationship; BIOLOGICAL EVALUATION; EFFICIENT SYNTHESIS; ADHATODA-VASICA; DERIVATIVES; CATALYST; DESIGN; 1,2-DIHYDROQUINAZOLIN-4(3H)-ONES; ALDEHYDES; SAMARIUM; WATER;
D O I：
10.1016/j.tube.2020.101986
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Quinazoline analogues are one of the important nitrogen containing heterocycles that have significant bioactivity as well as found in a plethora of natural products. Tuberculosis is one of the serious universal health threats caused by Mycobacterium tuberculosis (MTB) and primarily affects the lungs. Due to their significant bioactivity and natural occurrences of quinazolines, researchers are trying to synthesize new quinazoline analogues which may have significant potency against tuberculosis. This particular review summarizes recent development of different types of quinazoline bearing analogues as anti-tubercular (anti-TB) agents and their synthesis with structure-activity relationship.
引用
收藏
页数：19
相关论文
共 50 条
  • [41] Molecular modeling studies and anti-TB activity of trisubstituted indolizine analogues; molecular docking and dynamic inputs
    Khedr, Mohammed A.
    Pillay, Melendhran
    Chandrashekharappa, Sandeep
    Chopra, Deepak
    Aldhubiab, Bandar E.
    Attimarad, Mahesh
    Alwassil, Osama Ibrahim
    Mlisana, Koleka
    Odhav, Bharti
    Venugopala, Katharigatta N.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (08): : 2163 - 2178
  • [42] PREVENTION OF RESISTANCE TO NEW ANTI-TB DRUGS
    Varudkar, H. G.
    LUNG INDIA, 2005, 22 (04) : 142 - 145
  • [43] Synthesis, Molecular docking, Antioxidant, Anti-TB, and Potent MCF-7 Anticancer Studies of Novel Aryl-carbohydrazide Analogues
    Thorat, Bapu R.
    Mali, Suraj N.
    Wagh, Rahul R.
    Yamgar, Ramesh S.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2022, 18 (04) : 247 - 257
  • [44] Counting current anti-TB drug candidates
    不详
    LEPROSY REVIEW, 2002, 73 (01) : 102 - 102
  • [45] Chiron licenses novel anti-TB drug
    不详
    CHEMISTRY IN BRITAIN, 2002, 38 (04) : 10 - 10
  • [46] Recent Advances in Metal-Catalyzed Approaches for the Synthesis of Quinazoline Derivatives
    Nandwana, Nitesh K.
    Patel, Om P. S.
    Mehra, Manish K.
    Kumar, Anil
    Salvino, Joseph M.
    MOLECULES, 2024, 29 (10):
  • [47] Global overview of new anti-TB compounds
    Doi, N.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S17 - S18
  • [48] Quinolinyl Pyrimidines: Potent Inhibitors of NDH-2 as a Novel Class of Anti-TB Agents
    Shirude, Pravin S.
    Paul, Beena
    Choudhury, Nilanjana Roy
    Kedari, Chaitanya
    Bandodkar, Balachandra
    Ugarkar, Bheemarao G.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (09): : 736 - 740
  • [49] Recent Advances in the Synthesis of Tamoxifen and Analogues in Medicinal Chemistry
    Tandon, Nitin
    Luxami, Vijay
    Tandon, Runjhun
    Paul, Kamaldeep
    ASIAN JOURNAL OF ORGANIC CHEMISTRY, 2020, 9 (10) : 1432 - 1465
  • [50] Low serum levels of anti-TB drugs in a high TB setting
    Rodrigues, A. J. C.
    Barros, F. de Oliveira
    Martins, K. G. Pereira
    Almeida, T. H. Pacheco
    Matsuda, J. da Silva
    Mallmann, N. H.
    Anselmo, C. de Souza
    Sardela, V. F.
    Neto, J. P. de Moura
    Magalhaes, I. R. dos Santos
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2022, 26 (01) : 74 - 76
12345